CONTEXT AND OBJECTIVE
Lumiracoxib is an anti-inflammatory drug that has been used to treat acute dental pain, mainly in postsurgical settings, in which the greatest levels of pain and discomfort are experienced during the first 24 hours. This study aimed to assess the efficacy and safety of lumiracoxib for treating acute postsurgical dental pain.
DESIGN AND SETTING
Systematic review developed at the Brazilian Cochrane Centre, Universidade Federal de São Paulo.
METHODS
An electronic search was conducted in the PubMed, Cochrane Library, Lilacs (Literatura Latino-Americana e do Caribe em Ciências da Saúde), SciELO (Scientific Electronic Library Online) and Embase databases. A manual search was also performed. Only randomized controlled trials were included, and these were selected and assessed by two researchers with regard to the risk of bias.
RESULTS
Three clinical trials with 921 participants were included. Lumiracoxib 400 mg produced onset of analgesia in a shorter time than shown by lumiracoxib 100 mg, celecoxib 200 mg and ibuprofen 400 mg. There was no difference between lumiracoxib 400 mg and rofecoxib 50 mg. In two studies, the mean time taken to attain onset of analgesia for the placebo was not estimated because the number of participants who reached onset was too small.
CONCLUSION
There is evidence with a moderate risk of bias that recommends the use of lumiracoxib for acute postoperative dental pain. However, the adverse effects are not completely known. Given that lumiracoxib is currently available in only three countries, further studies are likely to be rare and discouraged.
[1]
R. Moore,et al.
Single dose oral lumiracoxib for postoperative pain.
,
2007,
The Cochrane database of systematic reviews.
[2]
T. Schnitzer,et al.
Lumiracoxib in the treatment of osteoarthritis, rheumatoid arthritis and acute postoperative dental pain: results of three dose-response studies
,
2005,
Current medical research and opinion.
[3]
D. Ott,et al.
Analgesic efficacy of a single dose of lumiracoxib compared with rofecoxib, celecoxib and placebo in the treatment of post‐operative dental pain
,
2004,
International journal of clinical practice.
[4]
J. Fricke,et al.
Analgesic efficacy of single oral doses of lumiracoxib and ibuprofen in patients with postoperative dental pain
,
2004,
International journal of clinical practice.
[5]
R. Melzack,et al.
Pain – an overview
,
1999,
Lancet.
[6]
A. Malmberg,et al.
Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat.
,
1992,
The Journal of pharmacology and experimental therapeutics.
[7]
S. Cooper,et al.
A model to evaluate mild analgesics in oral surgery outpatients
,
1976,
Clinical pharmacology and therapeutics.
[8]
V. Yu,et al.
Lumiracoxib 400 mg compared with celecoxib 400 mg and placebo for treating pain following dental surgery: a randomized, controlled trial.
,
2008,
The journal of pain : official journal of the American Pain Society.